Skip to content
2000
  • ISSN: 1568-0150
  • E-ISSN: 1875-6158

Abstract

Cholecystokinin (CCK) receptors are divided into CCK-1 (formerly CCK-A) and CCK-2 (formerly CCK-B) sub-types. CCK is a widely distributed neuropeptide in the brain and is considered a central nervous system transmitter. Possible therapeutic applications for CCK-2 antagonists include panic, anxiety, analgesia, schizophrenia, gastric disorders, and gastrointestinal tumours. This review covers the last five years findings in the field of such molecules

Loading

Article metrics loading...

/content/journals/cmccnsa/10.2174/1568015023357842
2002-12-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/cmccnsa/10.2174/1568015023357842
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test